Given that IL18 has also been reported to boost anti-tumor activity of human γδ T cells,10 we next set out to test whether GzB-IL18 armoring could be used to potentiate pCAR-H/T+ γδ T cells. This evidence concerns the gene IL18 and neoplasm.